Cargando…
1398. Successful Treatment of primary and refractory Echinococcus (Hydatid Cyst Disease) with Mefloquine and Mebendazole
BACKGROUND: Treatment regimens for relapsed or refractory Echinococcus (Hydatid cyst disease) are not well defined. Because seropositivity for Echinococcus disease is unpredictable, insurance coverage for expensive regimens are often denied. Improved, effective regimens are needed. Recent laboratory...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678183/ http://dx.doi.org/10.1093/ofid/ofad500.1235 |